Editor’s Note: Policy concerning screening for abdominal aortic aneurysm (AAA) may change on the basis of the Multicentre Aneurysm Screening Study (MASS) results, with the new recommendations to include screening all men older than 65 years, regardless of risk factors. The clinical results showing significant reduction in aneurysm-related mortality by about half appear in the Nov. 16 issue of The Lancet, while an economic analysis published on the same date in the British Medical Journal shows that it is cost-effective in the U.K. for men older than 65 years to be screened with abdominal ultrasound (links to a news article and the full text of the BMJ article are available at the bottom of this article).
What should doctors in the U.S do? Medscape’s Laurie Barclay interviewed Martin J. Buxton, BA, to help clarify the issue. He is a professor of health economics and director of the Health Economics Research Group at Brunel University in Uxbridge, Middlesex, in the U.K. His research interests include the refinement of quantitative and qualitative methodologies for economic evaluation of all types of health technologies. Prof. Buxton is responsible for the economic analysis of the MASS trial data published in the BMJ article.
e-Med Tools
קצר קולע וממוקד
e-Med סמינרים
אי-מד תחקירים
Medscape Tools
Journal Club
מרכזי מידע ושירות
Facebook
מידע למפרסם
מאגר תרופות
מאגר אנשי המקצוע
אינדקס שימושי
חדשות משה"ב
eMed HealthClub
מחקרים קליניים
השאירו תגובה
רוצה להצטרף לדיון?תרגישו חופשי לתרום!